Finance News

FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP

Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth

Business, Marketing

Greenwood Capital Relocates to MediaCityUK as Northern Business Demand Grows

SALFORD QUAYS, U.K. - -- Greenwood Capital, a UK business finance broker, has relocated its headquarters to MediaCityUK in Salford, citing strong demand from Northern businesses and the region's accelerating economic growth. The move, completed in...

Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP

NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase

Business, Marketing